Genmab A (GMAB) Times Interest Earned (2019 - 2026)
Genmab A's (GMAB) quarterly Times Interest Earned came in at 2.7 in Q2 2026, up 34.03% on a YoY basis from 2.01 in Q2 2025, and down 124.82% quarter-over-quarter from 1.2 in Q1 2026.
Powered by 
Analysis
Genmab A (GMAB) Times Interest Earned (2019 - 2026) Analysis & Trends
Genmab A (GMAB) has reported Times Interest Earned for 8 consecutive years, with 2.7 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Times Interest Earned rose 34.03% year-over-year to 2.7; the trailing twelve-month figure through Jun 2026 stood at 3.56 (down 49.3% YoY), and the FY2025 full-year result was 3.96, up 216.77% from the prior year.
- Times Interest Earned eased to 2.7 in Q2 2026 per GMAB's latest filing, from 1.2 in the prior quarter.
- Across five years, Times Interest Earned topped out at 11.33 in Q4 2023 and bottomed at 41.88 in Q3 2023.
- Historically, Times Interest Earned has averaged 5.05 across 5 years, with a median of 3.66 in 2024.
- The widest YoY moves for Times Interest Earned: up 91.27% in 2024, down 953.09% in 2024.
- Over 5 years, Times Interest Earned stood at 3.68 in 2022, then soared by 408.14% to 11.33 in 2023, then plunged by 132.27% to 3.66 in 2024, then sank by 61.96% to 5.92 in 2025, then jumped by 54.46% to 2.7 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered 2.7, 1.2, and 5.92 for Q2 2026, Q1 2026, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 5.22 |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | -42.08 |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 117.59 |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | - |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | 493.00 |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 2.82 |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | - |
| 10 | Genmab A | 2.23 Bn | 728.64 Mn | 1.07 Bn | 2.70 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.70 |
| Mar 31, 2026 | -1.20 |
| Sep 30, 2025 | -5.92 |
| Jun 30, 2025 | -4.09 |
| Mar 31, 2025 | -4.18 |
| Sep 30, 2024 | -3.66 |
| Jun 30, 2024 | -4.11 |
| Mar 31, 2024 | -3.31 |
| Dec 31, 2023 | 11.33 |
| Sep 30, 2023 | -41.88 |
| Jun 30, 2023 | -2.70 |
| Mar 31, 2023 | 0.39 |
| Jun 30, 2022 | -3.68 |
| Dec 31, 2021 | -1.83 |
| Sep 30, 2021 | -3.87 |
| Jun 30, 2021 | -1.83 |
| Mar 31, 2021 | -17.74 |
| Dec 31, 2020 | -21.31 |
| Sep 30, 2020 | 0.00 |
| Jun 30, 2020 | -19.51 |